| dc.contributor.author | Lynch, Julie | |
| dc.contributor.author | Nolan, Stephen | |
| dc.contributor.author | Slattery, Craig | |
| dc.contributor.author | Feighery, Ronan | |
| dc.contributor.author | Ryan, Michael P. | |
| dc.contributor.author | McMorrow, Tara | |
| dc.date.accessioned | 2012-06-12T14:17:43Z | |
| dc.date.available | 2012-06-12T14:17:43Z | |
| dc.date.copyright | 2010 Karger | en |
| dc.date.issued | 2010-11-24 | |
| dc.identifier.citation | American Journal of Nephrology | en |
| dc.identifier.uri | http://hdl.handle.net/10197/3631 | |
| dc.description.abstract | Background: High mobility group box protein 1 (HMGB-1) is a chromatin binding protein that bends DNA thereby facilitating gene transcription. HMGB-1 has also been observed as an extracellular secreted protein in serum of patients with sepsis and has putative intracellular signalling effects regulating the production of interleukin-1 and tumour necrosis factor in a number of inflammatory conditions. Methods: We established a model of immune-mediated epithelial-mesenchymal transition (EMT) in human proximal tubular epithelial cells (PTECs). PTECs were cultured with conditioned medium containing supernatant from activated peripheral blood mononuclear cells (aPBMC). The model was characterised using phenotypic and transcriptomic approaches and suppression subtractive hybridisation was performed to identify differentially regulated genes. Results. Activation of PBMCs resulted in increased secretion of HMGB-1. In addition, treatment of PTECs with aPBMC-conditioned medium resulted in significant upregulation of HMGB-1 in PTECs. Direct treatment of PTECs with recombinant human HMGB-1 induced alterations in epithelial morphology consistent with EMT including reduced E-cadherin expression, increased α-SMA expression and enhanced cell migration. HMGB-1 effects were mediated at least in part by the receptor for advanced glycation end products (RAGE) and through induction of TGF-β1 secretion from PTECs. Conclusions. These results suggest that HMGB-1 is a key mediator of immune-mediated EMT of PTECs and a potentially important signalling molecule in the development of renal fibrosis. | en |
| dc.description.sponsorship | Science Foundation Ireland | en |
| dc.description.sponsorship | Higher Education Authority | en |
| dc.description.sponsorship | Health Research Board | en |
| dc.description.sponsorship | Other funder | en |
| dc.format.extent | 1094997 bytes | |
| dc.format.mimetype | application/pdf | |
| dc.language.iso | en | en |
| dc.publisher | Karger | en |
| dc.relation.requires | Biomolecular and Biomedical Science Research Collection | en |
| dc.subject | Renal fibrosis | en |
| dc.subject | Epithelial-mesenchymal transition | en |
| dc.subject | PBMC | en |
| dc.subject | HMGB-1 | en |
| dc.subject.lcsh | Kidneys--Fibrosis | en |
| dc.subject.lcsh | Chromosomal proteins | en |
| dc.subject.lcsh | Blood cells | en |
| dc.subject.lcsh | Transforming growth factors-beta | en |
| dc.title | High-mobility group box protein 1: a novel mediator of inflammatory-induced renal epithelial-mesenchymal transition | en |
| dc.title.alternative | HMGB-1 - a novel mediator of inflammatory-induced renal epithelial mesenchymal transition | en |
| dc.type | Journal Article | en |
| dc.internal.availability | Full text available | en |
| dc.status | Peer reviewed | en |
| dc.identifier.volume | 32 | en |
| dc.identifier.issue | 6 | en |
| dc.identifier.startpage | 590 | en |
| dc.identifier.endpage | 602 | en |
| dc.identifier.doi | 10.1159/000320485 | |
| dc.neeo.contributor | Lynch|Julie|aut| | en |
| dc.neeo.contributor | Nolan|Stephen|aut| | en |
| dc.neeo.contributor | Slattery|Craig|aut| | en |
| dc.neeo.contributor | Feighery|Ronan|aut| | en |
| dc.neeo.contributor | Ryan|Michael P.|aut| | en |
| dc.neeo.contributor | McMorrow|Tara|aut| | en |
| dc.description.othersponsorship | Enterprise Ireland | en |
| dc.description.othersponsorship | Irish Nephrological Society | en |
| dc.description.othersponsorship | Amgen | en |
| dc.description.admin | sp, ab, ke, li - TS 15.05.12 | en |
This item is available under the Attribution-NonCommercial-NoDerivs 3.0 Ireland. No item may be reproduced for commercial purposes. For other possible restrictions on use please refer to the publisher's URL where this is made available, or to notes contained in the item itself. Other terms may apply.
If you are a publisher or author and have copyright concerns for any item, please email research.repository@ucd.ie and the item will be withdrawn immediately. The author or person responsible for depositing the article will be contacted within one business day.